BioArctic AB (publ) (LON:0RV2)

BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of GBP 1.90 billion. The enterprise value is 1.75 billion.

Market Cap	1.90B
Enterprise Value	1.75B

Important Dates

The last earnings date was Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.24M
Shares Outstanding	n/a
Shares Change (YoY)	+0.74%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	55.64M

Valuation Ratios

The trailing PE ratio is 23.16 and the forward PE ratio is 32.96.

PE Ratio	23.16
Forward PE	32.96
PS Ratio	13.29
PB Ratio	12.14
P/TBV Ratio	12.14
P/FCF Ratio	24.11
P/OCF Ratio	23.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.78, with an EV/FCF ratio of 22.23.

EV / Earnings	21.35
EV / Sales	11.87
EV / EBITDA	16.78
EV / EBIT	17.23
EV / FCF	22.23

Financial Position

The company has a current ratio of 8.63, with a Debt / Equity ratio of 0.02.

Current Ratio	8.63
Quick Ratio	7.40
Debt / Equity	0.02
Debt / EBITDA	0.04
Debt / FCF	0.05
Interest Coverage	43.08

Financial Efficiency

Return on equity (ROE) is 71.96% and return on invested capital (ROIC) is 52.09%.

Return on Equity (ROE)	71.96%
Return on Assets (ROA)	46.25%
Return on Invested Capital (ROIC)	52.09%
Return on Capital Employed (ROCE)	61.86%
Revenue Per Employee	1.20M
Profits Per Employee	688,179
Employee Count	107
Asset Turnover	1.07
Inventory Turnover	n/a

Taxes

In the past 12 months, BioArctic AB has paid 8.21 million in taxes.

Income Tax	8.21M
Effective Tax Rate	9.11%

Stock Price Statistics

The stock price has increased by +55.25% in the last 52 weeks. The beta is -0.70, so BioArctic AB's price volatility has been lower than the market average.

Beta (5Y)	-0.70
52-Week Price Change	+55.25%
50-Day Moving Average	238.06
200-Day Moving Average	207.22
Relative Strength Index (RSI)	52.02
Average Volume (20 Days)	19,330

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of GBP 142.74 million and earned 81.89 million in profits. Earnings per share was 0.92.

Revenue	142.74M
Gross Profit	138.75M
Operating Income	98.32M
Pretax Income	90.10M
Net Income	81.89M
EBITDA	99.89M
EBIT	98.32M
Earnings Per Share (EPS)	0.92

Balance Sheet

The company has 147.08 million in cash and 3.76 million in debt, giving a net cash position of 143.32 million.

Cash & Cash Equivalents	147.08M
Total Debt	3.76M
Net Cash	143.32M
Net Cash Per Share	n/a
Equity (Book Value)	156.28M
Book Value Per Share	1.77
Working Capital	151.66M

Cash Flow

In the last 12 months, operating cash flow was 80.69 million and capital expenditures -2.04 million, giving a free cash flow of 78.65 million.

Operating Cash Flow	80.69M
Capital Expenditures	-2.04M
Free Cash Flow	78.65M
FCF Per Share	n/a

Margins

Gross margin is 97.21%, with operating and profit margins of 68.88% and 57.37%.

Gross Margin	97.21%
Operating Margin	68.88%
Pretax Margin	63.12%
Profit Margin	57.37%
EBITDA Margin	69.99%
EBIT Margin	68.88%
FCF Margin	55.10%

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.74%
Shareholder Yield	n/a
Earnings Yield	4.32%
FCF Yield	4.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5